Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal Carcinoma

Clinical trial NCT02293356 · UNKNOWN

Trial details

NCT number: NCT02293356
Sponsor: Biotech Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2015-08-01
Primary completion: 2017-12-01
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.